News
Oncolytics Biotech Stock: Continuing To Justify The Negativity (NASDAQ:ONCY)
This article was written byFollowI have my PhD in biochemistry and have worked for years analyzing clinical trials and biotech…
Vail Resorts: Q2 Results Better Than Feared (NYSE:MTN)
This article was written byFollowOver fifteen years of experience making contrarian bets based on my macro view and stock-specific turnaround…
Mineralys: Prospects Just Got Better With Successful Pivotal Data Readouts (NASDAQ:MLYS)
This article was written byFollowTerry Chrisomalis is a private investor in the Biotech sector with years of experience utilizing his…
Asana, Inc. (ASAN) Q4 2025 Earnings Call Transcript
Asana, Inc. (NYSE:ASAN) Q4 2025 Earnings Conference Call March 10, 2025 4:30 PM ET Company Participants Eva Leung - Head…
Oracle Corporation (ORCL) Q3 2025 Earnings Call Transcript
Oracle Corporation (NYSE:ORCL) Q3 2025 Earnings Conference Call March 10, 2025 5:00 PM ET Company Participants Ken Bond - Head,…
AppFolio: GenAI Might Introduce More Differentiation In Its Products
This article was written byFollowI'm an Industrial Engineer. I read a lot of books and I'm very inspired by the…
Is It Time For Elon Musk And Tesla To Part Ways? (Downgrade To ‘Hold’)
This article was written byFollowAfter 43+ years working for one investment research company or another, I finally retired. So now,…
Polen U.S. SMID Company Growth Portfolio Q4 2024 Commentary
Summary In 2024, U.S. SMID cap growth stocks were dominated by narrow performance drivers—crowded AI trades and interest rate-sensitive sectors…